| Source HCPCS Code |
|
Target NDC Code |
C9093
Inj, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
|
⇄
|
50242-0078-12
SUSVIMO 10 MG/0.1 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/01/2022 |
| Relationship End Date |
06/30/2022 |
| Number Of Items In Ndc Package |
0.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IL |
| Billing Units |
ML |
|
|
|
C9093
Inj, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
|
⇄
|
50242-0078-55
SUSVIMO 10 MG/0.1 ML KIT
|
| Detail Information |
| Relationship Start Date |
04/01/2022 |
| Relationship End Date |
06/30/2022 |
| Number Of Items In Ndc Package |
0.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
KIT |
| Route Of Administration |
IL |
| Billing Units |
ML |
|
|
|